NERV Q1 2025 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$58M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.50

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$33M

Total Liabilities

$62M

Stockholders' Equity

-$29M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$4M	-$7M	+41.6%
Net Income	-$4M	-$9M	+56.2%